Successful treatment of mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: A case report

Journal of Medical Case Reports

Volumn 2, Issue , 2008, Pages

  O'Brien, Daniel P ^a,b,c   Athan, Eugene ^a   Hughes, Andrew ^a   Johnson, Paul D ^d  

^a GEELONG HOSPITAL   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CIPROFLOXACIN; CLARITHROMYCIN; ETHAMBUTOL; RIFAMPICIN;

ADD ON THERAPY; AGED; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; DEBRIDEMENT; DRUG WITHDRAWAL; FEMALE; HUMAN; MONOTHERAPY; MYCOBACTERIUM ULCERANS; OSTEOMYELITIS; OTOTOXICITY; PRIORITY JOURNAL; TREATMENT DURATION;

EID: 45149115568     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-2-123     Document Type: Article

References (11)

1. Portaels F Aguiar J Debacker M Guedenon A Steunou C Zinsou C Meyers WM Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease Infect Immun 2004, 72:62-65. 343964 14688081 10.1128/IAI.72.1.62-65.2004
2. Etuaful SC Carbonnelle B Grosset J Lucas S Horsefield C Phillips R Evans M Ofori-Adjei D Klustse E Owusu-Boateng J Amedofu GK Awuah P Ampadu E Amofah G Asiedu K Wansbrough-Jones M Bactericidal activity of rifampicin and streptomycin treatment for early human M. ulcerans lesions Report of the Sixth WHO Advisory Group Meeting on Buruli Ulcer: Geneva, Switzerland 2003:101-102.
3. O'Brien DP Hughes AJ Cheng AC Henry MJ Callan P McDonald A Holten I Birrell M Sowerby JM Johnson PD Athan E Improved outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: Findings from a south-eastern Australian case series Med J Aust 2007, 186:58-61. 17223763
4. Ross BC Marino L Oppedisano F Edwards R Roibbins-Browne RM Jounson PD Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection J Clin Microbiol 1997, 35:1696-1700. 229824 9196176
5. Hofer M Hirschel B Kirschner P Beghetti M Kaelin A Siegrist CA Suter S Teske A Bottger EC Brief report: Disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite N Engl J Med 1993, 328:1007-1009. 10.1056/NEJM199304083281405 8450852
6. Pszolla N Sarkar MR Strecker W Kern P Kinzl L Meyers WM Portaels F Buruli ulcer: A systemic disease Clin Infect Dis 2003, 37(6):. 12955667
7. Thangaraj HS Adjei O Allen BW Portaels F Evans MR Banerjee DK Wansbrough-Jones MH In vitro activity of ciprofloxacin, sparfloxacin, ofloxacin, amikacin and rifampicin against Ghanaian isolates of Mycobacterium ulcerans J Antimicrob Chemother 2000, 45:231-233. 10.1093/ jac/45.2.231 10660507
8. Bentoucha A Robert J Dega H Lounis N Jarlier V Grosset J Activities of new macrolides and fluoroquinolones against Mycobacterium ulcerans infection in mice Antimicrob Agents Chemother 2001, 45:3109-3112. 90790 11600364 10.1128/AAC.45.11.3109-3112.2001
9. Dhople AM Namba K Activities of sitafloxacin (DU-6859a), either singly or in combination with rifampin, against Mycobacterium ulcerans infection in mice J Chemother 2003, 15:47-52. 12678414
10. Marsollier L Honore N Legras P Manceau AL Kouakou H Carbonnelle B Cole ST Isolation of three Mycobacterium ulcerans strains resistant to rifampin after experimental chemotherapy of mice Antimicrob Agents Chemother 2003, 47:1228-1232. 152492 12654651 10.1128/ AAC.47.4.1228-1232.2003
11. Van der Werf TS van der Graaf WT Tappero JW Asiedu K Mycobacterium ulcerans infection Lancet 1999, 354:1013-1018. 10.1016/ S0140-6736(99)01156-3 10501380